Lenacapavir—time to change the game for everyone The Lancet Infectious Diseases ++... ++

Lenacapavir—time to change the game for everyone The Lancet Infectious Diseases https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00667-X/fulltext?dgcid=raven_jbs_etoc_email Dec 2025 Volume 25Number 12p1265-1376, e677-e739 https://www.thelancet.com/journals/laninf/issue/vol25no12/PIIS1473-3099(25)X0012-8 Estimating measles susceptibility and transmission patterns in Italy: an epidemiological assessment https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00293-2/abstract?dgcid=raven_jbs_etoc_feature_laninf Human papillomavirus (HPV) type 16 and type 18 antibody concentrations after a single dose of bivalent HPV vaccine in girls aged 9–14 years compared with three doses of quadrivalent HPV vaccine in women aged 18–25 years in Costa Rica (PRIMAVERA): a non-randomised, open-label, immunobridging, non-inferiority trial https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00284-1/fulltext?dgcid=raven_jbs_etoc_feature_laninf